National Physicians Alliance Endorses HEAL Act to address antibiotic resistance

Contact: Becky Martin, Tel: 202-420-7896


Washington DC—February 13, 2015

The National Physicians Alliance (NPA) endorses the Helping Effective Antibiotics Last (HEAL) Act, to address the problem of antibiotic-resistant superbugs. Solutions to antibiotic resistance must be multifaceted, including both the development of innovative antibiotics that are safe and effective and the prevention of antibiotic overuse and misuse.

“The HEAL Act goes further than current proposals to address antibiotic resistance,” says Lisa Plymate, MD, Chair of the NPA FDA Taskforce. “The Act supports streamlined development of effective new antibiotics, the responsible use of existing antibiotics, and the safety of patients. It ensures new treatments are not merely new, but are also effective and safe—the heart of what matters to patients and physicians alike.  The Act is grounded in science and it will save lives.”

Unlike previously introduced bills ADAPT and PATH, the HEAL Act ensures that antibiotics are approved based on well-designed clinical trials done in humans, rather than allowing approval based only on animal studies or mathematical modeling.